Search
Patexia Community

Innovation, Technology, and IP News

Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023

The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...

The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma

Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...

Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says

Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...

FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications

  Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...

Feed tagged as "severe depression":
Electroconvulsive therapy (ECT) was introduced in the 1930s as a psychiatric treatment for patients suffering from severe depression.  Because this method... Read More »
Researchers at Massachusetts General Hospital (MGH) found that a blood test to diagnose major depression could become a useful tool after a study showed success in... Read More »
Comments
Robert PowersIt would be crazy if they can identify other personality disorders blood analysis.
Feb 1, 2012
Canada’s Centre for Addiction and Mental Health has found that employees treated for depression are more likely to be highly productive. This study testing the... Read More »
Menu